+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biodefense - A Global Market Overview

  • PDF Icon

    Report

  • 255 Pages
  • September 2024
  • Region: Global
  • Industry Experts
  • ID: 6008233
Biodefense refers to a comprehensive strategy to safeguard against biological threats, including bioterrorism, biological warfare agents, and emerging infectious diseases. It encompasses a range of actions aimed at preventing, detecting, and responding to biological attacks or outbreaks. These actions include developing and deploying medical countermeasures like vaccines and therapeutics, enhancing surveillance systems, implementing biosecurity measures, and establishing emergency response protocols. Biodefense aims to reduce the impact of biological agents and ensure readiness for potential biological emergencies. This requires collaboration among bioscience labs, hospitals, customs, and public health sectors to prevent the use of dangerous pathogens and toxins.

The global Biodefense market is estimated at US$18.2 billion in 2024 and is anticipated to register a CAGR of 8.6% during the 2024-2030 analysis period and stand at a projected US$29.9 billion by 2030.

The Biodefense market is driven by technological advancements, rising global health hazards, and substantial government investments. Key drivers include the rapid development of next-generation vaccines and treatments; with artificial intelligence (AI) and machine learning (ML) enhancing early detection and response systems; advances in biodetection technology and point-of-care diagnostics improve outbreak response and early warning capabilities; biosecurity measures are strengthening research facilities and high-risk sectors to prevent pathogen spread; collaborative efforts between governments, academia, and businesses accelerate R&D and technology transfer; and increased government funding, prompted by the threats of bioterrorism and pandemics, fuels market expansion. The COVID-19 pandemic has heightened awareness of healthcare vulnerabilities, driving a focus on bio-surveillance, vaccine development, and emergency response mechanisms. Climate change and global travel increase zoonotic disease risks, further fueling market growth.

Biodefense Regional Market Analysis

In 2024, North America, led by the U.S., dominated the biodefense market with a 46% share due to significant government investment, robust R&D capabilities, and a strong emphasis on national security. The U.S. government's initiatives, such as the BioShield Act, and the presence of major industry players have bolstered this position. Conversely, the Asia Pacific region is poised to grow rapidly, with a forecast CAGR of 10.5% from 2024-2030, driven by increased R&D investments and rising biothreat incidents. Countries like China, India, Japan, and South Korea are enhancing biodefense capabilities and investing heavily in public health preparedness, making the Asia Pacific the fastest-growing market segment.

Biodefense Market Analysis by Product Type

The anthrax segment leads the market, holding a notable share of 27.8% in 2024. This is attributed to its significant public health impact and ease of dispersion. Anthrax, caused by the Bacillus anthracis bacterium, poses a major bioterrorism threat due to its spore form, which can endure lengthy periods in the environment and spread easily. This segment sees substantial investments in vaccines and countermeasures, driven by past bioterrorism events and ongoing concerns. On the other hand, the ''Other Products'' segment, which includes diseases such as Influenza, Viral Hemorrhagic Fevers, Ebola, Zika, and others, is expected to grow the fastest with a CAGR of 10.5% from 2024 to 2030. This rapid growth is propelled by the recent rise in infections and the development of new vaccines and treatments for diseases like Zika, Ebola, and Nipah as companies strive to tackle these emerging threats.

Biodefense Market Analysis by Application

The Military segment is projected to hold the largest market share at 64.5% in 2024, driven by substantial government investment in advanced technologies, research, and medical countermeasures to protect national security. The high perceived risk of biological threats and the strategic importance of military preparedness drive extensive funding and development efforts, ensuring robust defenses against potential bioterrorism and biological attacks. Conversely, the Civilian segment is expected to grow rapidly with a CAGR of 9.1% from 2024 to 2030, due to rising biological threats from terrorist organizations. This growth reflects heightened government efforts and research focused on protecting civilians from potential biological attacks and emerging viruses.

Biodefense Market Analysis by End-User

The hospitals and clinics segment dominates the biodefense market with a 47.1% share in 2024 and is projected to record the fastest CAGR of 9.2% from 2024-2030. This is due to their critical role in managing and treating biological attacks, requiring advanced infrastructure, protective equipment, and diagnostic tools. Their capacity to handle mass casualties and enhance biodefense preparedness drives their dominant market position. The 'Other End Users' segment, which includes research organizations, biotechnology firms, and government agencies, is experiencing significant market growth driven by increased investment in biodefense research and development, leading to robust performance.

Biodefense Market Report Scope

This global report on Biodefense analyzes the market based on product, application, and end users. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.

Key Metrics

  • Historical Period: 2021-2023
  • Base Year: 2023
  • Forecast Period: 2024-2030
  • Units: Value market in US$
  • Companies Mentioned: 15+

Biodefense Market by Geographic Region

  • North America (The United States, Canada, and Mexico)
  • Europe (Germany, France, The United Kingdom, Spain, Italy, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, and Rest of South America)
  • Rest of World

Biodefense Market by Product

  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear
  • Others (Including Influenza, Plague, Cholera, Food Poisoning, Viral Hemorrhagic Fevers, Brucellosis, Glanders, Melioidosis, Tularemia, Viral Encephalitis, Ebola Virus, Zica Virus, Nipah Virus, and Hantavirus)

Biodefense Market by Application

  • Military
  • Civilian

Biodefense Market by End User

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Other End Users (Including Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Government Agencies, and Emergency Responders)


This product will be delivered within 2-4 business days.

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
  • Product Outline
  • Biodefense Defined
  • Biodefense Products
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear
  • Other Products
  • Biodefense Applications
  • Military
  • Civilian
  • Biodefense End Users
  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Other End Users
2. Key Market Trends
3. Key Global Players
  • Alnylam Pharmaceuticals Inc
  • Altimmune Inc
  • Bavarian Nordic
  • Dynavax Technologies Corporation
  • Dynport Vaccine Company
  • Elusys Therapeutics
  • Emergent Biosolutions
  • GlaxoSmithKline (UK)
  • Ichor Medical Systems
  • Ology Bioservices
  • Sanofi
  • SIGA Technologies
  • Soligenix
  • Statera BioPharma, Inc.
  • Xoma Corporation
4. Key Business & Product Trends
5. Global Market Overview
  • Global Biodefense Market Overview by Product
  • Biodefense Product Type Market Overview by Global Region
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear
  • Other Products
  • Global Biodefense Market Overview by Application
  • Biodefense Application Market Overview by Global Region
  • Military
  • Civilian
  • Global Biodefense Market Overview by End User
  • Biodefense End User Market Overview by Global Region
  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Other End Users
PART B: REGIONAL MARKET PERSPECTIVE
  • Global Biodefense Market Overview by Geographic Region
6. North America
  • North American Biodefense Market Overview by Geographic Region
  • North American Biodefense Market Overview by Product
  • North American Biodefense Market Overview by Application
  • North American Biodefense Market Overview by End User
  • Country-wise Analysis of North American Biodefense Market
  • The United States
  • United States Biodefense Market Overview by Product
  • United States Biodefense Market Overview by Application
  • United States Biodefense Market Overview by End User
  • Canada
  • Canadian Biodefense Market Overview by Product
  • Canadian Biodefense Market Overview by Application
  • Canadian Biodefense Market Overview by End User
  • Mexico
  • Mexican Biodefense Market Overview by Product
  • Mexican Biodefense Market Overview by Application
  • Mexican Biodefense Market Overview by End User
7. Europe
  • European Biodefense Market Overview by Geographic Region
  • European Biodefense Market Overview by Product
  • European Biodefense Market Overview by Application
  • European Biodefense Market Overview by End User
  • Country-wise Analysis of European Biodefense Market
  • Germany
  • German Biodefense Market Overview by Product
  • German Biodefense Market Overview by Application
  • German Biodefense Market Overview by End User
  • France
  • French Biodefense Market Overview by Product
  • French Biodefense Market Overview by Application
  • French Biodefense Market Overview by End User
  • The United Kingdom
  • United Kingdom Biodefense Market Overview by Product
  • United Kingdom Biodefense Market Overview by Application
  • United Kingdom Biodefense Market Overview by End User
  • Spain
  • Spanish Biodefense Market Overview by Product
  • Spanish Biodefense Market Overview by Application
  • Spanish Biodefense Market Overview by End User
  • Italy
  • Italian Biodefense Market Overview by Product
  • Italian Biodefense Market Overview by Application
  • Italian Biodefense Market Overview by End User
  • Rest of Europe
  • Rest of Europe Biodefense Market Overview by Product
  • Rest of Europe Biodefense Market Overview by Application
  • Rest of Europe Biodefense Market Overview by End User
8. Asia-Pacific
  • Asia-Pacific Biodefense Market Overview by Geographic Region
  • Asia-Pacific Biodefense Market Overview by Product
  • Asia-Pacific Biodefense Market Overview by Application
  • Asia-Pacific Biodefense Market Overview by End User
  • Country-wise Analysis of Asia-Pacific Biodefense Market
  • Japan
  • Japanese Biodefense Market Overview by Product
  • Japanese Biodefense Market Overview by Application
  • Japanese Biodefense Market Overview by End User
  • China
  • Chinese Biodefense Market Overview by Product
  • Chinese Biodefense Market Overview by Application
  • Chinese Biodefense Market Overview by End User
  • India
  • Indian Biodefense Market Overview by Product
  • Indian Biodefense Market Overview by Application
  • Indian Biodefense Market Overview by End User
  • South Korea
  • South Korean Biodefense Market Overview by Product
  • South Korean Biodefense Market Overview by Application
  • South Korean Biodefense Market Overview by End User
  • Rest of Asia-Pacific
  • Rest of Asia-Pacific Biodefense Market Overview by Product
  • Rest of Asia-Pacific Biodefense Market Overview by Application
  • Rest of Asia-Pacific Biodefense Market Overview by End User
9. South America
  • South American Biodefense Market Overview by Geographic Region
  • South American Biodefense Market Overview by Product
  • South American Biodefense Market Overview by Application
  • South American Biodefense Market Overview by End User
  • Country-wise Analysis of Asia-Pacific Biodefense Market
  • Brazil
  • Brazilian Biodefense Market Overview by Product
  • Brazilian Biodefense Market Overview by Application
  • Brazilian Biodefense Market Overview by End User
  • Argentina
  • Argentine Biodefense Market Overview by Product
  • Argentine Biodefense Market Overview by Application
  • Argentine Biodefense Market Overview by End User
  • Rest of South America
  • Rest of South American Biodefense Market Overview by Product
  • Rest of South American Biodefense Market Overview by Application
  • Rest of South American Biodefense Market Overview by End User
10. Rest of World
  • Rest of World Biodefense Market Overview by Product
  • Rest of World Biodefense Market Overview by Application
  • Rest of World Biodefense Market Overview by End User
PART C: GUIDE TO THE INDUSTRYPART D: ANNEXURE1. Research Methodology2. Feedback

Companies Mentioned

  • Alnylam Pharmaceuticals Inc
  • Altimmune Inc
  • Bavarian Nordic
  • Dynavax Technologies Corporation
  • Dynport Vaccine Company
  • Elusys Therapeutics
  • Emergent Biosolutions
  • GlaxoSmithKline (UK)
  • Ichor Medical Systems
  • Ology Bioservices
  • Sanofi
  • SIGA Technologies
  • Soligenix
  • Statera BioPharma, Inc.
  • Xoma Corporation

Table Information